Hayder Abdul Razak
About Hayder Abdul Razak
Hayder Abdul Razak is a Senior Scientist at Asklepios BioPharmaceutical, Inc. in Edinburgh, Scotland, where he has worked since 2019, focusing on gene therapy and coordinating studies with academic collaborators.
Work at Asklepios BioPharmaceutical
Hayder Abdul Razak has been serving as a Senior Scientist at Asklepios BioPharmaceutical, Inc. (AskBio) since 2019. His role is based in Edinburgh, Scotland, United Kingdom. In this position, he coordinates studies with academic collaborators and is involved in writing project proposals and reports. His work focuses on gene therapy, particularly utilizing AAVs and lentiviral vectors to address inherited diseases.
Previous Experience at Royal Holloway, University of London
Prior to his current role, Hayder Abdul Razak worked at Royal Holloway, University of London for a total of eight years. He served as a Practical Demonstrator from 2008 to 2012 and later as a Postdoctoral Researcher from 2012 to 2014. He continued his tenure at Royal Holloway as a Senior Postdoctoral Researcher from 2014 to 2018. His experience at this institution contributed to his expertise in gene therapy.
Experience at University College London
Hayder Abdul Razak also held the position of Senior Scientist at University College London (UCL) from 2019 to 2021. This role further developed his skills and knowledge in the field of gene therapy, complementing his extensive background in research and collaboration.
Education and Expertise
Hayder Abdul Razak earned his PhD in Gene/Genetic Therapy from Royal Holloway, University of London, where he studied from 2008 to 2012. His academic background laid the foundation for his extensive experience with AAVs and lentiviral vectors, focusing on gene therapy applications aimed at combating inherited diseases. He holds a personal and project animals license, enabling him to design, conduct, and manage animal studies.